Dow Up 0.35% Nasdaq Down 0.02%

Mylan, Inc. (MYL)

-NasdaqGS
48.59 1.55(3.30%) Aug 20, 4:00PM EDT
Prev Close:47.04
Open:47.10
Bid:44.96 x 200
Ask:51.90 x 100
1y Target Est:60.38
Beta:1.12
Earnings Date:Oct 29 - Nov 3 (Est.)
Day's Range:46.86 - 48.85
52wk Range:34.46 - 57.52
Volume:7,589,440
Avg Vol (3m):4,397,360
Market Cap:18.17B
P/E (ttm):30.35
EPS (ttm):1.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MYLUp 3.30%18.17B
ACT59.03B
TEVA45.24B

Key Statistics

Forward P/E (1 yr):12.49
P/S (ttm):2.47
Ex-Dividend Date:27-Jun-07

Analysts

Annual EPS Est (Dec-14) :3.29
Quarterly EPS Est (Sep-14) :0.94
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Mylan Inc., a pharmaceutical company, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback